Roach P D, Hosking J, Clifton P M, Bais R, Kusenic B, Coyle P, Wight M B, Thomas D W, Nestel P J
CSIRO (Australia) Division of Human Nutrition, Adelaide.
Atherosclerosis. 1993 Nov;103(2):245-54. doi: 10.1016/0021-9150(93)90267-x.
The in vivo expression and regulation of the LDL receptor of circulating mononuclear cells was studied using a sensitive spectrophotometric assay with low density lipoproteins conjugated to colloidal gold (LDL-gold). The high plasma cholesterol of familial hypercholesterolemic subjects was shown to be related to a low in vivo LDL receptor activity; cells from a homozygote had virtually no activity and those from 24 heterozygotes expressed 45% of the activity of cells from 35 normals. The average receptor activity of cells from 18 polygenic hypercholesterolemic (PH) subjects was not significantly different from normal but a low expression may have been a factor in six of these subjects. Simvastatin increased the LDL receptor activity of cells from the PH subjects by 70% while lowering their plasma cholesterol by 26%, but reducing the fat intake from 38% to 20% of energy and cholesterol from 239 to 96 mg/day had no effect on the receptor despite a 10% reduction in plasma cholesterol. Upregulation of the LDL receptor may therefore have been involved in the lowering of plasma cholesterol by simvastatin but not by the reduction in dietary fat and cholesterol.
采用与胶体金偶联的低密度脂蛋白(LDL-金)的灵敏分光光度法,研究了循环单核细胞中LDL受体的体内表达和调节。家族性高胆固醇血症患者的高血浆胆固醇与体内LDL受体活性低有关;纯合子的细胞几乎没有活性,24名杂合子的细胞表达的活性为35名正常人细胞活性的45%。18名多基因高胆固醇血症(PH)患者的细胞平均受体活性与正常情况无显著差异,但其中6名患者的低表达可能是一个因素。辛伐他汀使PH患者细胞的LDL受体活性增加70%,同时使他们的血浆胆固醇降低26%,但将脂肪摄入量从能量的38%降至20%,胆固醇摄入量从239毫克/天降至96毫克/天,尽管血浆胆固醇降低了10%,但对受体没有影响。因此,LDL受体的上调可能参与了辛伐他汀降低血浆胆固醇的过程,但与饮食中脂肪和胆固醇的减少无关。